Perhexiline. by Ashrafian, H, Horowitz, J, Frenneaux, M

Augmentation of glucose metabolism with perhexiline in non-ischaemic heart failure by Lee, L, Scheurmann-Freestone, M, Campbell, R, Field, R, Gunaruwan, P, Horowitz, J, Clarke, K, Frenneaux, M

Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. by Lee, L, Campbell, R, Scheuermann-Freestone, M, Taylor, R, Gunaruwan, P, Williams, L, Ashrafian, H, Horowitz, J, Fraser, A, Clarke, K, Frenneaux, M

Prevalence and clinical features of inflammatory bowel diseases associated with monogenetic variants, identified by whole-exome sequencing in 1000 children at a single center by Crowley, E, Warner, N, Pan, J, Khalouei, S, Elkadri, A, Fiedler, K, Foong, J, Turinsky, AL, Bronte-Tinkew, D, Zhang, S, Hu, J, Tian, D, Li, D, Horowitz, J, Siddiqui, I, Upton, J, Roifman, CM, Church, PC, Wall, DA, Ramani, AK, Kotlarz, D, Klein, C, Uhlig, H, Snapper, SB, Gonzaga-Jauregui, C, Paterson, AD, McGovern, PB, Brudno, M, Walters, TD, Griffiths, AM, Muise, AM